BRAND: Ezetimibe/Simvastatin Rowex
ACTIVE INGREDIENT: Ezetimibe/Simvastatin
STRENGTH & PACK SIZE & GMS CODES:
Ezetimibe/Simvastatin Rowex 10mg/20mg Tablets x 28 GMS Number 37035
Ezetimibe/Simvastatin Rowex 10mg/40mg Tablets x 28 GMS Number 37036
Ezetimibe/Simvastatin Rowex 10mg/80mg Tablets x 28 GMS Number 37037
Prevention of cardiovascular events
Ezetimibe/Simvastatin Rowex is indicated to reduce the risk of cardiovascular events (see section 5.1) in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.
Ezetimibe/Simvastatin Rowex is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:
- Patients not appropriately controlled with a statin alone
- Patients already treated with a statin and ezetimibe
Homozygous familial hypercholesterolaemia (HoFH)
Ezetimibe/Simvastatin Rowex is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).